HCV treatment decision-making substance use experiences and hepatitis C treatment decision-making among HIV/HCV Coinfected Adults.
Hepatitis C virus (HCV) infection is a major source of morbidity and mortality among substance users and persons living with human immunodeficiency virus (HIV) infection. Treatment for chronic HCV infection involves complex decision-making. These decisions are even more complicated in persons with HIV and substance use related problems. A secondary analyses of qualitative data collected in the United States (2004-2005) with 31 HIV/HCV coinfected adults (48% women; mean age 44.7 years) revealed three themes related to substance use (substance use evolution, revolving door: going back out and reconstructing life) and two HCV treatment decision-making themes (HCV infection treatment issues: not a priority, fear, misinformation and get clean and try it). Study limitations and implications are discussed.
Ogawa
Lisa M Fink
LM
University of Massachusetts Worcester, Graduate School of Nursing, Worcester, Massachusetts 01655, USA. Lisa.ogawa@umassmed.edu
Bova
Carol
C
D000328:Adult; D003657:Decision Making; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000523:psychology*; D006526:Hepatitis C / Q000150:complications / Q000523:psychology* / Q000628:therapy; D006801:Humans; D008297:Male; D010342:Patient Acceptance of Health Care / Q000523:psychology*; D019966:Substance-Related Disorders / Q000150:complications / Q000523:psychology*